Bronchi Cystic Fibrosis

Elexacaftor-Tezacaftor-Ivacaftor Reduces Bronchial Widening and Thickening in Adolescents With Cystic Fibrosis

Lan Mi2025-06-11T13:17:05+00:00

Elexacaftor-Tezacaftor-Ivacaftor Reduces Bronchial Widening and Thickening in Adolescents With Cystic FibrosisLan Mi2025-06-11T13:17:05+00:00

Introduction of Ivacaftor/Lumacaftor in Children With Cystic Fibrosis Homozygous for F508del in the Netherlands: A Nationwide Real-Life Study

Lan Mi2025-06-05T12:16:52+00:00

Introduction of Ivacaftor/Lumacaftor in Children With Cystic Fibrosis Homozygous for F508del in the Netherlands: A Nationwide Real-Life StudyLan Mi2025-06-05T12:16:52+00:00

Fully Automatic Assessment of Bronchus-Artery Dimensions and Ratios, Mucus Plugs, and Low Attenuation Regions in Cystic Fibrosis Patients Before and After Elexacaftor-Tezacaftor-Ivacaftor

admin2024-05-29T11:18:43+00:00

Fully Automatic Assessment of Bronchus-Artery Dimensions and Ratios, Mucus Plugs, and Low Attenuation Regions in Cystic Fibrosis Patients Before and After Elexacaftor-Tezacaftor-Ivacaftoradmin2024-05-29T11:18:43+00:00

Azithromycin reduces bronchial wall thickening in infants with cystic fibrosis

admin2024-05-07T12:21:50+00:00

Azithromycin reduces bronchial wall thickening in infants with cystic fibrosisadmin2024-05-07T12:21:50+00:00

The clinical impact of Lumacaftor-Ivacaftor on structural lung disease and lung function in children aged 6–11 with cystic fibrosis in a real-world setting

admin2023-10-23T11:24:52+00:00

The clinical impact of Lumacaftor-Ivacaftor on structural lung disease and lung function in children aged 6–11 with cystic fibrosis in a real-world settingadmin2023-10-23T11:24:52+00:00

Automatic Bronchus and Artery Analysis on Chest Computed Tomography to Evaluate the Effect of Inhaled Hypertonic Saline in Children Aged 3-6 Years With Cystic Fibrosis in a Randomized Clinical Trial

admin2023-10-23T11:24:56+00:00

Automatic Bronchus and Artery Analysis on Chest Computed Tomography to Evaluate the Effect of Inhaled Hypertonic Saline in Children Aged 3-6 Years With Cystic Fibrosis in a Randomized Clinical Trialadmin2023-10-23T11:24:56+00:00

Sensitive automated airway-artery method to monitor progression of CF airway disease

admin2025-05-15T12:22:07+00:00

Sensitive automated airway-artery method to monitor progression of CF airway diseaseadmin2025-05-15T12:22:07+00:00

Objective airway artery dimensions compared to CT scoring methods assessing structural cystic fibrosis lung disease

admin2023-10-23T11:34:53+00:00

Objective airway artery dimensions compared to CT scoring methods assessing structural cystic fibrosis lung diseaseadmin2023-10-23T11:34:53+00:00